Dexamethasone and Surgical-Site Infection.

Tomás B CorcoranPaul S MylesAndrew B ForbesAllen C ChengLeon A BachEdmond O'LoughlinKate LeslieMatthew T V ChanDavid StoryTimothy G ShortCatherine MartinPauline CouttsKwok M Honull nullnull nullnull null

Published in: The New England journal of medicine (2021)

Dexamethasone was noninferior to placebo with respect to the incidence of surgical-site infection within 30 days after nonurgent, noncardiac surgery. (Funded by the Australian National Health and Medical Research Council and others; PADDI Australian New Zealand Clinical Trials Registry number, ACTRN12614001226695.).

Keyphrases

surgical site infection
clinical trial
high dose
low dose
healthcare
risk factors
double blind
open label
acute coronary syndrome